Tien Lee, Aardvark Therapeutics CEO

Aard­vark nabs $85M to tar­get hunger, not ap­petite, as it eyes 2026 NDA fil­ing

A small San Diego biotech wants to take a dif­fer­ent ap­proach to the weight loss drug R&D field by go­ing af­ter hunger rather than sup­press­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.